Core Viewpoint - A securities class action lawsuit has been filed against Canopy Growth Corporation for failing to disclose significant costs related to product launches, which negatively impacted financial results and gross margins [1][2]. Group 1: Lawsuit Details - The lawsuit is on behalf of all individuals or entities that purchased Canopy securities between May 30, 2024, and February 6, 2025 [1]. - Allegations include failure to disclose significant costs associated with the Claybourne pre-rolled joints and indirect costs from Storz & Bickel vaporizer devices [2]. Group 2: Financial Impact - Canopy announced disappointing financial results on February 7, 2025, attributing them to costs from the Claybourne product launch and increased indirect costs [3]. - Following the announcement, Canopy's share price dropped by 27.24%, closing at $2.02 on the same day [3]. Group 3: Investor Information - Investors who acquired Canopy shares are encouraged to contact the law firm before the lead plaintiff motion deadline of June 3, 2025 [4].

NEW YORK, April 8, 2025 /PRNewswire/ -- Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of securities of Canopy Growth Corporation (NASDAQ: CGC) between May 30, 2024 and February 6, 2025, both dates inclusive (the "Class Period"). A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than June 3, 2025.So What: If you purchased Canopy Growth securities during the Class P ...

LOS ANGELES, April 8, 2025 /PRNewswire/ -- The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Canopy Growth Corporation ("Canopy Growth" or "the Company") (NASDAQ: CGC) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.Investors who purchased the Company's securities between May 30, 2024 and February 6, 2025, inclusive (the "Class ...

NEW YORK, April 07, 2025 (GLOBE NEWSWIRE) -- Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Canopy Growth Corporation (“Canopy” or “the Company”) (NASDAQ: CGC) and certain of its officers. Class Definition This lawsuit seeks to recover damages against Defendants for alleged violations of the federal securities laws on behalf of all persons and entities that purchased or otherwise acquired Can ...

Core Viewpoint - Robbins LLP has initiated a class action lawsuit on behalf of investors who purchased Canopy Growth Corporation (CGC) securities between May 30, 2024, and February 6, 2025, alleging that the company misled investors regarding its cost reduction measures and financial health [1][2]. Group 1: Allegations Against Canopy Growth Corporation - The lawsuit claims that Canopy Growth Corporation failed to disclose significant costs associated with the production of Claybourne pre-rolled joints and indirect costs related to Storz & Bickel vaporizer devices, which negatively impacted the company's gross margins and overall financial results [2]. - It is alleged that the company overstated the effectiveness of its cost reduction measures while downplaying issues related to its gross margins [2]. Group 2: Financial Impact and Stock Performance - On February 7, 2025, Canopy announced disappointing financial results attributed to the costs from the Claybourne product launch and increased indirect costs, leading to a 27.24% drop in share price, closing at $2.02 [3]. Group 3: Class Action Participation - Shareholders interested in serving as lead plaintiffs in the class action must contact Robbins LLP before June 3, 2025, although participation is not required to be eligible for recovery [4].

Core Viewpoint - A class action lawsuit has been filed against Canopy Growth Corporation for allegedly misleading investors regarding its cost reduction measures and financial performance during a specified period [1][2]. Allegations - The lawsuit claims that Canopy Growth Corporation failed to disclose significant costs associated with the production of Claybourne pre-rolled joints and indirect costs related to Storz & Bickel vaporizer devices, which negatively impacted the company's gross margins and overall financial results [2]. - It is alleged that the company overstated the effectiveness of its cost reduction measures while downplaying issues related to its gross margins [2]. Financial Impact - On February 7, 2025, Canopy announced disappointing financial results attributed to the costs from the Claybourne product launch and increased indirect costs, leading to a 27.24% drop in share price, closing at $2.02 [3]. Class Action Participation - Shareholders may be eligible to participate in the class action against Canopy Growth Corporation, with a deadline for lead plaintiff applications set for June 3, 2025 [4]. Company Background - Robbins LLP is noted as a leader in shareholder rights litigation, focusing on helping shareholders recover losses and improve corporate governance since 2002 [5].

Toronto, Ontario--(Newsfile Corp. - March 27, 2025) - Canadian Gold Corp. (TSXV: CGC) ("Canadian Gold" or the "Company") is pleased to announce that it has closed its non-brokered financing previously announced on March 10, 2025. The Company issued 8,823,529 charity flow-through shares (the "Charity FT Shares") at a price of $0.28 per Charity FT Share and 2,941,176 common share units (the "Share Units") at a price of $0.17 per Share Unit for aggregate gross proceeds to the Company of approximately $3 milli ...

Core Insights - Canadian cannabis stocks are under close observation due to their ties to the expanding U.S. market, which could reach $72 billion by 2030 [1][21] - The U.S. Department of Health and Human Services has recommended rescheduling cannabis to Schedule III, increasing optimism for federal reform [1] - Key Canadian companies with U.S. exposure include Tilray Brands, Canopy Growth Corporation, and Village Farms International, each with distinct strategies and financial positions [3][21] Group 1: Tilray Brands, Inc. (TLRY) - Tilray is a prominent player in the global cannabis market, focusing on strategic partnerships and acquisitions in the U.S. despite federal restrictions [4][6] - The company reported revenue of $177 million, a 34% year-over-year increase, driven by beverage and wellness sales, while cannabis revenue grew modestly [8] - Tilray's long-term strategy aims for profitability and a strong position in cannabis, wellness, and beverages, with a $20 million share repurchase program indicating confidence in future performance [7][9] Group 2: Canopy Growth Corporation (CGC) - Canopy Growth, once the largest cannabis stock in Canada, is now focused on profitability and capturing U.S. market share through investments in Acreage Holdings and Wana Brands [9][11] - The company reported revenue of $62 million, a 21% year-over-year decline, with net losses of $216 million, although it showed improvement in U.S. CBD and wellness divisions [13] - Canopy is restructuring to save $100 million annually and is simplifying its business model to focus on high-growth segments [14][15] Group 3: Village Farms International, Inc. (VFF) - Village Farms operates in both cannabis and produce industries, providing a buffer against cannabis market volatility [15][16] - The company reported revenue of $71 million, with cannabis sales contributing $29 million, and a net loss of $9.5 million, which was narrower than previous losses [18][20] - Village Farms is committed to cost discipline and has a strong balance sheet, ending the quarter with over $20 million in cash and minimal debt, positioning it well for future growth [20]

Core Insights - Wana Brands has launched its hemp-derived Delta-9 THC gummies in Texas, marking the 22nd state for product availability, emphasizing the company's commitment to safe and reliable cannabis products [1][2] - The expansion into Texas aligns with the evolving cannabis landscape in the state, allowing Wana to meet consumer demand through strategic retail placements [2] - Wana Brands prioritizes quality and safety, with all products undergoing rigorous third-party testing for potency, purity, and contaminants [3] Company Strategy - The expansion beyond the Wanderous marketplace is a key growth strategy for Wana, aiming to capture market share by increasing product accessibility at local retail locations [4] - Wana's mission focuses on enhancing lives through plant-powered products and providing consumers with the education needed for informed choices [4] Company Background - Wana is recognized as North America's most trusted edibles brand, with a presence in multiple U.S. states, Puerto Rico, and Canada, founded in 2010 [5] - Canopy USA, the parent company of Wana, holds a non-controlling interest in Canopy Growth and is strategically positioned in high-potential segments of the U.S. cannabis market [6]

Core Insights - Wana Brands has expanded its distribution by partnering with Total Wine & More, making its hemp-infused beverages available nationwide, reflecting the growing consumer demand for health-conscious, zero-proof alcohol alternatives [1][4] Company Overview - Wana Brands is recognized as North America's leading edibles provider, founded in 2010, with a mission to enhance lives through innovative cannabis products backed by research and lab testing [6] - Canopy USA, a holding company with a non-controlling interest from Canopy Growth, owns Wana Brands and is strategically positioned in high-potential segments of the U.S. cannabis market [7] Product Offerings - Wana Beverages include a line of ready-to-drink sparkling beverages infused with hemp extracts and real fruit juice, available in 12 oz cans with three flavor and effect combinations: - Wana Lemonade Balance Blend: 5mg CBG, 5mg CBD, 5mg THC [3][8] - Wana Strawberry Lemonade Balance Blend: 10mg CBG, 10mg CBD, 10mg THC [8] - Wana Raspberry Tea Relax Blend: 5mg CBG, 5mg CBD, 5mg THC [8] Market Trends - The demand for alcohol alternatives is at an all-time high, and the partnership with Total Wine & More aims to reach a new segment of cannabis-curious consumers [4]